Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-9729Fax+1 214-648-9289
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Nuclear Medicine, 2002 - 2004
- Berkshire Medical CenterInternship, Internal Medicine, 2001 - 2002
- Albany Medical CollegeClass of 2001
- Yale Divinity SchoolM.A.R., Religion, 1991 - 1994
- Columbia CollegeA.B., Religion, 1987 - 1991
Certifications & Licensure
- TX State Medical License 2023 - 2026
- LA State Medical License 2019 - 2024
- GA State Medical License 2006 - 2020
- NY State Medical License 2002 - 2008
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- Survey of Clinical Protocols for the Use ofLu-PSMA-617 in the United States.Phillip H Kuo, Matthew F Covington, Daniel J Lee, Terence Z Wong, Neeta Pandit-Taskar
Journal of Nuclear Medicine Technology. 2024-09-05 - Novel Biodistribution of PSMA Radiotracer in the Uvula of Patients Undergoing PSMA PET/CT.Phaethon Philbrook, Kelsey R Casano, Daniel J Lee
Clinical Nuclear Medicine. 2024-02-01 - 24 citationsDosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.Neeta Pandit-Taskar, Amir Iravani, Dan Lee, Heather A. Jacene, Dan Pryma
Journal of Nuclear Medicine. 2021-12-01
Journal Articles
- The Nuclear Medicine Care Coordination Service: A Model for Radiologist-Driven Patient Centered CareMoncayo VM, Appkegate KE, Duszak R, Barron B, Fitz J, Halkar RK, Lee DJ, Schuster DM, Academic Radiology, 1/1/2015
- Unusual suspects: pulmonary opportunistic infections masquerading as tumor metastasis in a patient with adrenocorticotropic hormone-producing pancreatic neuroendocrin...Chowdry RP, Bhimani C, Delgado MA, Lee DJ, Dayamani P, Sica GL, Owonikoko TK, Therapeutic Advances in Medical Oncology, 1/1/2012
- Recognizing the artifacts and minimizing untoward effects caused by failed or complicated radiopharmaceutical injectionsMoncayo V, Brandon D, Lee D, Bonta D, Halkar R, Journal of Nuclear Medicine, 1/1/2012
- Join now to see all
Abstracts/Posters
- FDG PET/CT in the diagnosis of a lymphoma patient with lower extremity painSepulveda JN, Lloyd K, Zeng W, Lee D, Journal of Nuclear Medicine, 1/1/2008
- Optimizing hepatobiliary scan for diagnosis of acute cholecystitisEhsan S, Lee D, Esteves F, Halkar R, Journal of Nuclear Medicine, 1/1/2008
- PET/CT as a predictor of survivals in patients with ovarian cancer following first line therapyCho S, Halkar R, Lee D, Journal of Nuclear Medicine, 1/1/2008
- Join now to see all
Lectures
- 131-I MIBG Therapy for Neuroendocrine MalignanciesSan Antonio, TX - 1/23/2015
- Benign Thyroid Disease – Evaluation and Treatment Pulmonary ScintigraphyAugusta, GA - 1/7/2015
- Radium-223: A Physician’s PerspectiveLake Buena Vista, FL - 1/11/2014
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: